In an 82‑year‑old woman with two coronary stents placed 18 years ago who is on low‑dose aspirin, should aspirin be discontinued one week before parathyroid adenoma resection for hyperparathyroidism, or can it be continued through the day of surgery without increasing bleeding risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Continue Aspirin Through Surgery

In this 82-year-old woman with stents placed 18 years ago, aspirin should be continued through the day of parathyroid surgery without interruption. The cardiovascular risk of stopping aspirin far outweighs the bleeding risk for this neck surgery.

Key Clinical Reasoning

Why Continue Aspirin?

The stent thrombosis risk is now minimal (18 years post-placement), but the general cardiovascular protection from aspirin remains critical. Even though her stents are remote, she has established coronary artery disease requiring secondary prevention 1, 2.

  • Parathyroid surgery is an intermediate bleeding-risk procedure – it's neck surgery with good visualization and hemostatic control, not intracranial, spinal canal, or posterior eye chamber surgery where aspirin absolutely must stop 3, 4
  • The 2024 ACC/AHA guidelines explicitly state aspirin continuation is reasonable when cardiac event risk outweighs bleeding risk 2
  • Multiple guidelines confirm aspirin monotherapy can continue for most surgeries 1, 5

The Real Bleeding Risk

Aspirin increases bleeding frequency by approximately 1.5-fold but does NOT increase severity of bleeding complications or mortality 6. For parathyroid surgery specifically:

  • Increased oozing or minor hematoma formation may occur
  • This does NOT translate to life-threatening hemorrhage in the neck with proper surgical technique
  • Surgeons can achieve excellent hemostasis even with aspirin on board
  • The bleeding is manageable and does not require reoperation in the vast majority of cases

The Cardiovascular Risk of Stopping

Stopping aspirin creates a 3-fold increased risk of major adverse cardiac events, with events occurring as early as 8.5 days after discontinuation 7, 6:

  • At age 82, she has significant baseline cardiovascular risk
  • Aspirin withdrawal can precipitate acute coronary syndrome even without recent stents
  • The perioperative period itself is prothrombotic
  • One week off aspirin puts her in the highest-risk window during and after surgery

Common Pitfalls to Avoid

  1. Don't reflexively stop all antiplatelet agents – The old practice of stopping aspirin 7-10 days before surgery is outdated and dangerous 4, 8

  2. Don't confuse this with recent stent scenarios – Her 18-year-old stents are fully endothelialized; stent thrombosis is not the concern here. The issue is general CAD protection 3

  3. Don't equate minor bleeding with harm – More gauze use or slightly longer operative time does not equal worse outcomes 6

Specific Management Plan

Preoperatively:

  • Continue aspirin 81 mg daily through the morning of surgery
  • Inform the surgeon and anesthesiologist that aspirin is being continued
  • Ensure surgeon is experienced and comfortable operating with aspirin on board

Intraoperatively:

  • Meticulous surgical technique with careful hemostasis
  • Consider leaving a small drain if surgeon prefers (though often unnecessary)

Postoperatively:

  • Continue aspirin 81 mg daily starting the evening of surgery or next morning
  • Monitor surgical site for hematoma (standard practice regardless)
  • Most neck hematomas present within 6-24 hours and are managed conservatively

The Evidence Hierarchy

The 2024 ACC/AHA perioperative guidelines 2 and 2022 CHEST guidelines 9 represent the most current evidence. Both support aspirin continuation for patients with CAD undergoing non-cardiac surgery when bleeding risk is not prohibitive. The French Task Force 3 specifically categorized procedures and recommended aspirin continuation for intermediate-risk surgeries. The 2014 ICUD/AUA guidelines 5 confirmed that patients with cardiac risk factors on aspirin can continue it without increased major bleeding risk.

Parathyroid adenoma resection falls squarely into the category where aspirin should continue – it's not intracranial, not spinal canal, not posterior eye chamber, and not associated with massive blood loss like major vascular or cancer surgery 3, 4.

Bottom Line

The bleeding risk with continued aspirin during parathyroid surgery is real but minor (more oozing, possibly longer operative time). The cardiovascular risk of stopping aspirin for one week is substantial and potentially fatal. Keep the aspirin going.

References

Research

Antiplatelet agents in the perioperative period.

Archives of surgery (Chicago, Ill. : 1960), 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.